Division of Microbiology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
J Biol Chem. 2011 Sep 23;286(38):33622-31. doi: 10.1074/jbc.M111.258673. Epub 2011 Aug 3.
Chronic infection with Helicobacter pylori cagA-positive strains is associated with atrophic gastritis, peptic ulceration, and gastric carcinoma. The cagA gene product, CagA, is delivered into gastric epithelial cells via type IV secretion, where it undergoes tyrosine phosphorylation at the EPIYA motifs. Tyrosine-phosphorylated CagA binds and aberrantly activates the oncogenic tyrosine phosphatase SHP2, which mediates induction of elongated cell morphology (hummingbird phenotype) that reflects CagA virulence. CagA also binds and inhibits the polarity-regulating kinase partitioning-defective 1 (PAR1)/microtubule affinity-regulating kinase (MARK) via the CagA multimerization (CM) sequence independently of tyrosine phosphorylation. Because PAR1 exists as a homodimer, two CagA proteins appear to be passively dimerized through complex formation with a PAR1 dimer in cells. Interestingly, a CagA mutant that lacks the CM sequence displays a reduced SHP2 binding activity and exhibits an attenuated ability to induce the hummingbird phenotype, indicating that the CagA-PAR1 interaction also influences the morphological transformation. Here we investigated the role of CagA dimerization in induction of the hummingbird phenotype with the use of a chemical dimerizer, coumermycin. We found that CagA dimerization markedly stabilizes the CagA-SHP2 complex and thereby potentiates SHP2 deregulation, causing an increase in the number of hummingbird cells. Protrusions of hummingbird cells induced by chemical dimerization of CagA are further elongated by simultaneous inhibition of PAR1. This study revealed a role of the CM sequence in amplifying the magnitude of SHP2 deregulation by CagA, which, in conjunction with the CM sequence-mediated inhibition of PAR1, evokes morphological transformation that reflects in vivo CagA virulence.
慢性感染幽门螺杆菌 cagA 阳性菌株与萎缩性胃炎、消化性溃疡和胃癌有关。cagA 基因产物 CagA 通过 IV 型分泌系统进入胃上皮细胞,在 EPIYA 基序处发生酪氨酸磷酸化。酪氨酸磷酸化的 CagA 结合并异常激活致癌酪氨酸磷酸酶 SHP2,介导长形细胞形态(蜂鸟表型)的诱导,反映 CagA 的毒力。CagA 还通过 CagA 多聚化(CM)序列结合并抑制极性调节激酶分配缺陷 1(PAR1)/微管亲和力调节激酶(MARK),而不依赖于酪氨酸磷酸化。由于 PAR1 作为同源二聚体存在,两个 CagA 蛋白似乎通过与细胞中 PAR1 二聚体的复合物被动二聚化。有趣的是,缺乏 CM 序列的 CagA 突变体显示出降低的 SHP2 结合活性,并表现出降低的诱导蜂鸟表型的能力,表明 CagA-PAR1 相互作用也影响形态转化。在这里,我们使用化学二聚体 coumermycin 研究了 CagA 二聚化在诱导蜂鸟表型中的作用。我们发现 CagA 二聚化显著稳定了 CagA-SHP2 复合物,从而增强了 SHP2 的失调,导致蜂鸟细胞数量增加。通过 CagA 的化学二聚化诱导的蜂鸟细胞突起通过同时抑制 PAR1 进一步延长。这项研究揭示了 CM 序列在放大 CagA 引起的 SHP2 失调幅度方面的作用,这与 CM 序列介导的 PAR1 抑制一起,引发反映体内 CagA 毒力的形态转化。